NewsBite

Michael Smith

This Month

‘You’re too nice’: How this chief executive proved her sceptics wrong

Telstra Health’s Elizabeth Koff, winner of the Financial Review Women in Leadership Awards Health category, says she was never ambitious growing up but had the courage to speak up.

Mayne Pharma sells products in Australia and the US for birth control and menopause treatments.

Proxy advisers support Mayne Pharma deal as suitor tries to exit

US private equity backed pharmaceutical giant Cosette attempt to terminate its bid for Mayne Pharma is facing opposition from proxy advisers and activists.

Mayne Pharma sells products in Australia and the US for birth control and menopause treatments.

Cosette terminates $672m Mayne Pharma deal as legal challenge looms

The private-equity backed American giant began reviewing the deal two weeks ago because of concerns about its target’s financial performance since it first bid.

Eli Lilly’s Mounjaro medication.

TGA approves weight-loss drug to treat sleep disorder

The medicines regulator has approved Eli Lilly’s Mounjaro weight-loss drug to be used to treat sleep apnoea.

Psychologists will face the biggest pay increase of up to 31 per cent.

How specialist fees of $900 per visit are hurting private hospitals

Australians are paying hundreds of dollars to see a doctor that they cannot claim back on health insurance.

Advertisement
Healthscope chief executive Tino La Spina says there are no winners from Brookfield’s investment.

Healthscope chief Tino La Spina says Bupa takeover ‘over my dead body’

In a frank briefing with medical staff, the collapsed private hospital giant’s boss said former owner Brookfield had left with its “tail between its legs”.

May

Healthscope’s terminal prognosis could be just the start

Another eight private hospitals are earmarked for closure as the operator’s collapse raises questions about the business model.

A major Healthscope landlord has agreed to a partial rent deferral to keep hospitals open.

Di Pilla grants Healthscope rent relief to keep hospitals open

The owner of 11 Healthscope hospitals says it has had expressions of interest for alternative operators.

PolyActiva chief executive Vanessa Waddell and National Reconstruction Fund chief executive David Gall in the Melbourne laboratories where trials of the biotech’s eye implant technology have been taking place.

Labor takes $27m stake in breakthrough eye biotech

Melbourne biotech PolyActiva says it hopes to be the next Cochlear by selling its eye drug dispensing system to millions globally.

From Redfern to the outback and back to the boardroom for NIB’s Welsh

Brad Welsh says his experience working with communities around the country helps him understand NIB’s customer base.

Foreign hedge funds could take equity stakes in Healthscope if they cannot find the right buyer.

Hedge funds weigh up longer-term ownership of collapsed Healthscope

Polus Capital and Canyon Partners are considering whether they should tip money into the failed hospital operator amid questions about private equity ownership.

Keith Crawford of McGrathNicol has been tasked with selling Healthscope. He is pictured with the company’s chief executive Tino La Spina at the John Fawkner Hospital in Melbourne.

States demand assurances from Butler after Healthscope collapse

The future of the failed private hospital giant is partly in the hands of five Chinese state-owned banks and asset managers which control a fifth of its debt.

Healthscope chief executive Tino La Spina says it is business as usual for the country’s second-largest hospital operator.

Healthscope lifeline to keep hospitals afloat amid buyer search

While the company says it has 10 prospective suitors, Health Minister Mark Butler has flagged that overseas private equity firms are unacceptable hospital owners.

Healthscope runs hospitals across Australia, including Darwin Private Hospital.

Healthscope in critical condition as it fights to stave off receivers

The hedge funds that control its debt are pushing to place the country’s second-biggest private hospital operator in the hands of administrators this week.

Getting medicated has never been easier, and Canberra is worried

Online prescriptions – for everything from weight loss to medicinal cannabis – is now a big business backed by Woolworths and NIB. But regulation is coming.

Advertisement
Mayne Pharma sells products in Australia and the US for birth control and menopause treatments.

Mayne Pharma shares crash after suitor Cosette threatens to walk

Shares in the drug company fell 30 per cent on Wednesday after its takeover suitor said there had been a material adverse change in its performance.

Monash IVF shares have fallen 40 per cent since an embryo mix-up at its Brisbane clinic was reported in April.

Monash IVF downgrades full-year profit outlook

Analysts blame Monash IVF’s profit downgrade on softer volumes industry-wide rather than an exodus of patients following its Brisbane embryo mix-up.

Bupa’s Asia Pacific chief executive Nick Stone and global chief executive Inaki Ereno in Melbourne on Tuesday.

Bupa to open 60 mental health clinics in primary care push

The health insurer has set a course to become one of Australia’s biggest mental health providers within three years.

A scheme designed to help chronically ill Australians pay for medical treatment is being increasingly misused by “shonky” and “greedy” practitioners, prompting calls from a wide range of experts for a crackdown as well as better checks and balances.

Australia moves towards a US-style health system - is that a good thing?

Private insurance funds already control some dental, optical and mental health clinics. Could hospitals be next?

The Belongil Beach home Damien Gance and Sasha Robertson recently bought for $33.5 million.

Billionaire Chemist Warehouse scion cashes out a further $380m

Sigma Healthcare director Damien Gance has sold about two-thirds of his shares in the company for $800 million since its merger with Chemist Warehouse.

Original URL: https://www.afr.com/by/michael-smith-j7geb